

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | urate metabolic process (GO:0046415) | 7.32125902 |
| 2 | drug transmembrane transport (GO:0006855) | 7.12561310 |
| 3 | lysine metabolic process (GO:0006553) | 6.65312069 |
| 4 | lysine catabolic process (GO:0006554) | 6.65312069 |
| 5 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 6.60852295 |
| 6 | cysteine metabolic process (GO:0006534) | 6.43842999 |
| 7 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.06648008 |
| 8 | L-phenylalanine catabolic process (GO:0006559) | 6.06648008 |
| 9 | homocysteine metabolic process (GO:0050667) | 5.97556929 |
| 10 | L-phenylalanine metabolic process (GO:0006558) | 5.86373035 |
| 11 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.86373035 |
| 12 | nephron tubule formation (GO:0072079) | 5.83206878 |
| 13 | drug transport (GO:0015893) | 5.82267514 |
| 14 | glyoxylate metabolic process (GO:0046487) | 5.71964525 |
| 15 | aromatic amino acid family catabolic process (GO:0009074) | 5.52742830 |
| 16 | negative regulation of metanephros development (GO:0072217) | 5.28844516 |
| 17 | organic cation transport (GO:0015695) | 5.21824276 |
| 18 | drug catabolic process (GO:0042737) | 5.17242302 |
| 19 | phosphate ion transport (GO:0006817) | 5.04679486 |
| 20 | tryptophan catabolic process (GO:0006569) | 5.01149516 |
| 21 | indole-containing compound catabolic process (GO:0042436) | 5.01149516 |
| 22 | indolalkylamine catabolic process (GO:0046218) | 5.01149516 |
| 23 | tryptophan metabolic process (GO:0006568) | 4.83701661 |
| 24 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 4.78520520 |
| 25 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 4.75953458 |
| 26 | aminoglycoside antibiotic metabolic process (GO:0030647) | 4.75042727 |
| 27 | response to mercury ion (GO:0046689) | 4.68608702 |
| 28 | kynurenine metabolic process (GO:0070189) | 4.58694571 |
| 29 | aspartate family amino acid catabolic process (GO:0009068) | 4.58184986 |
| 30 | serine family amino acid catabolic process (GO:0009071) | 4.56675819 |
| 31 | phosphate ion transmembrane transport (GO:0035435) | 4.54345821 |
| 32 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.54009303 |
| 33 | amino-acid betaine metabolic process (GO:0006577) | 4.52358785 |
| 34 | vitamin D metabolic process (GO:0042359) | 4.51486205 |
| 35 | sulfur amino acid catabolic process (GO:0000098) | 4.42042873 |
| 36 | short-chain fatty acid metabolic process (GO:0046459) | 4.39780414 |
| 37 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.38952261 |
| 38 | exogenous drug catabolic process (GO:0042738) | 4.38760240 |
| 39 | cellular modified amino acid catabolic process (GO:0042219) | 4.37871121 |
| 40 | quaternary ammonium group transport (GO:0015697) | 4.31448603 |
| 41 | tricarboxylic acid metabolic process (GO:0072350) | 4.25769319 |
| 42 | collecting duct development (GO:0072044) | 4.25333421 |
| 43 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 4.25193971 |
| 44 | valine metabolic process (GO:0006573) | 4.19541732 |
| 45 | actin filament depolymerization (GO:0030042) | 4.19196428 |
| 46 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 4.12844741 |
| 47 | excretion (GO:0007588) | 4.11694609 |
| 48 | serine family amino acid metabolic process (GO:0009069) | 4.07218874 |
| 49 | 2-oxoglutarate metabolic process (GO:0006103) | 4.04612976 |
| 50 | regulation of bile acid biosynthetic process (GO:0070857) | 4.03638921 |
| 51 | flavonoid metabolic process (GO:0009812) | 4.03177264 |
| 52 | glutamate metabolic process (GO:0006536) | 4.01912806 |
| 53 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338) | 4.00825304 |
| 54 | aromatic amino acid family metabolic process (GO:0009072) | 4.00207220 |
| 55 | glomerular visceral epithelial cell development (GO:0072015) | 3.99738391 |
| 56 | cellular glucuronidation (GO:0052695) | 3.97656498 |
| 57 | alpha-amino acid catabolic process (GO:1901606) | 3.92968497 |
| 58 | renal absorption (GO:0070293) | 3.91667642 |
| 59 | intestinal cholesterol absorption (GO:0030299) | 3.87215963 |
| 60 | branched-chain amino acid metabolic process (GO:0009081) | 3.84899519 |
| 61 | bile acid biosynthetic process (GO:0006699) | 3.83669966 |
| 62 | metanephric nephron tubule development (GO:0072234) | 3.81381765 |
| 63 | metanephric tubule development (GO:0072170) | 3.81381765 |
| 64 | cellular amino acid catabolic process (GO:0009063) | 3.81236105 |
| 65 | fatty acid beta-oxidation (GO:0006635) | 3.80523428 |
| 66 | uronic acid metabolic process (GO:0006063) | 3.72244990 |
| 67 | glucuronate metabolic process (GO:0019585) | 3.72244990 |
| 68 | regulation of complement activation (GO:0030449) | 3.72001671 |
| 69 | regulation of metanephros development (GO:0072215) | 3.71859547 |
| 70 | nephron tubule development (GO:0072080) | 3.71240312 |
| 71 | alpha-linolenic acid metabolic process (GO:0036109) | 3.71093557 |
| 72 | cellular ketone body metabolic process (GO:0046950) | 3.70700342 |
| 73 | regulation of protein activation cascade (GO:2000257) | 3.70699695 |
| 74 | metanephric nephron epithelium development (GO:0072243) | 3.68450251 |
| 75 | fatty acid oxidation (GO:0019395) | 3.68322713 |
| 76 | negative regulation of protein activation cascade (GO:2000258) | 3.68240134 |
| 77 | acetyl-CoA metabolic process (GO:0006084) | 3.66926810 |
| 78 | drug metabolic process (GO:0017144) | 3.66616922 |
| 79 | cardiovascular system development (GO:0072358) | 3.65620326 |
| 80 | negative regulation of complement activation (GO:0045916) | 3.61141126 |
| 81 | indolalkylamine metabolic process (GO:0006586) | 3.60418140 |
| 82 | lipid oxidation (GO:0034440) | 3.60060554 |
| 83 | epoxygenase P450 pathway (GO:0019373) | 3.59952963 |
| 84 | regulation of cholesterol homeostasis (GO:2000188) | 3.59802315 |
| 85 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.56713278 |
| 86 | carnitine metabolic process (GO:0009437) | 3.53695196 |
| 87 | regulation of mesenchymal cell apoptotic process (GO:2001053) | 3.52413753 |
| 88 | positive regulation of glomerulus development (GO:0090193) | 3.52020078 |
| 89 | amino-acid betaine transport (GO:0015838) | 3.50857841 |
| 90 | carnitine transport (GO:0015879) | 3.50857841 |
| 91 | transepithelial transport (GO:0070633) | 3.48663531 |
| 92 | serine family amino acid biosynthetic process (GO:0009070) | 3.47278606 |
| 93 | fatty acid catabolic process (GO:0009062) | 3.46061811 |
| 94 | glomerular epithelial cell development (GO:0072310) | 3.44039971 |
| 95 | omega-hydroxylase P450 pathway (GO:0097267) | 3.43750237 |
| 96 | organic acid catabolic process (GO:0016054) | 3.42741750 |
| 97 | carboxylic acid catabolic process (GO:0046395) | 3.42741750 |
| 98 | cell volume homeostasis (GO:0006884) | 3.41687190 |
| 99 | urea metabolic process (GO:0019627) | 3.41402457 |
| 100 | urea cycle (GO:0000050) | 3.41402457 |
| 101 | toxin transport (GO:1901998) | 3.41200807 |
| 102 | positive regulation of metanephros development (GO:0072216) | 3.39394654 |
| 103 | bile acid metabolic process (GO:0008206) | 3.37969015 |
| 104 | benzene-containing compound metabolic process (GO:0042537) | 3.37863014 |
| 105 | branched-chain amino acid catabolic process (GO:0009083) | 3.36541794 |
| 106 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.36514557 |
| 107 | monocarboxylic acid catabolic process (GO:0072329) | 3.36267774 |
| 108 | metanephric epithelium development (GO:0072207) | 3.35542741 |
| 109 | renal tubule development (GO:0061326) | 3.33938250 |
| 110 | phosphate ion homeostasis (GO:0055062) | 3.27857260 |
| 111 | trivalent inorganic anion homeostasis (GO:0072506) | 3.27857260 |
| 112 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.26677716 |
| 113 | tyrosine metabolic process (GO:0006570) | 3.25084467 |
| 114 | negative regulation of cholesterol transport (GO:0032375) | 3.20163831 |
| 115 | negative regulation of sterol transport (GO:0032372) | 3.20163831 |
| 116 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.19988189 |
| 117 | protein carboxylation (GO:0018214) | 3.19988189 |
| 118 | amine catabolic process (GO:0009310) | 3.19329677 |
| 119 | cellular biogenic amine catabolic process (GO:0042402) | 3.19329677 |
| 120 | glutathione biosynthetic process (GO:0006750) | 3.18933442 |
| 121 | nitrogen cycle metabolic process (GO:0071941) | 3.18742961 |
| 122 | regulation of stem cell maintenance (GO:2000036) | 3.18460704 |
| 123 | regulation of branching involved in ureteric bud morphogenesis (GO:0090189) | 3.16891114 |
| 124 | ketone body metabolic process (GO:1902224) | 3.15468460 |
| 125 | proline metabolic process (GO:0006560) | 3.13299495 |
| 126 | response to lead ion (GO:0010288) | 3.11709453 |
| 127 | response to phenylpropanoid (GO:0080184) | 3.09641216 |
| 128 | sphingoid metabolic process (GO:0046519) | 3.09458905 |
| 129 | peptide catabolic process (GO:0043171) | 3.06097061 |
| 130 | cell differentiation involved in metanephros development (GO:0072202) | 3.05264248 |
| 131 | nephron epithelium development (GO:0072009) | 3.05187007 |
| 132 | nephron epithelium morphogenesis (GO:0072088) | 3.04723141 |
| 133 | nephron tubule morphogenesis (GO:0072078) | 3.04723141 |
| 134 | response to growth hormone (GO:0060416) | 3.03695048 |
| 135 | biotin metabolic process (GO:0006768) | 3.03566523 |
| 136 | negative regulation of kidney development (GO:0090185) | 3.03406322 |
| 137 | response to water (GO:0009415) | 3.03088605 |
| 138 | regulation of hippo signaling (GO:0035330) | 3.02331581 |
| 139 | sodium-independent organic anion transport (GO:0043252) | 3.00779606 |
| 140 | positive regulation of catenin import into nucleus (GO:0035413) | 2.99084638 |
| 141 | coenzyme catabolic process (GO:0009109) | 2.98556981 |
| 142 | regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095) | 2.98047525 |
| 143 | polyol transport (GO:0015791) | 2.96993613 |
| 144 | regulation of acrosome reaction (GO:0060046) | 2.94709666 |
| 145 | negative regulation of catenin import into nucleus (GO:0035414) | 2.94699999 |
| 146 | complement activation, alternative pathway (GO:0006957) | 2.92993983 |
| 147 | oxidative demethylation (GO:0070989) | 2.89418672 |
| 148 | indole-containing compound metabolic process (GO:0042430) | 2.88420552 |
| 149 | response to parathyroid hormone (GO:0071107) | 2.83150094 |
| 150 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.82711975 |
| 151 | xenobiotic catabolic process (GO:0042178) | 2.76626334 |
| 152 | bone remodeling (GO:0046849) | 2.76218414 |
| 153 | sphingosine metabolic process (GO:0006670) | 2.74305688 |
| 154 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.69154518 |
| 155 | endocrine hormone secretion (GO:0060986) | 2.65369206 |
| 156 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 2.64916557 |
| 157 | regulation of mesonephros development (GO:0061217) | 2.62074650 |
| 158 | negative regulation of humoral immune response (GO:0002921) | 2.58743480 |
| 159 | regulation of non-canonical Wnt signaling pathway (GO:2000050) | 2.57751685 |
| 160 | positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190) | 2.56143389 |
| 161 | sulfation (GO:0051923) | 2.55849648 |
| 162 | mesonephros development (GO:0001823) | 2.52525012 |
| 163 | sodium ion homeostasis (GO:0055078) | 2.50980340 |
| 164 | lung lobe morphogenesis (GO:0060463) | 2.49454332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.85254919 |
| 2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.90267091 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.96554987 |
| 4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.91941383 |
| 5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.85994856 |
| 6 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.38271464 |
| 7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.32408282 |
| 8 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.12769669 |
| 9 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.11524376 |
| 10 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.73544880 |
| 11 | GATA1_22025678_ChIP-Seq_K562_Human | 2.58714282 |
| 12 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.20811371 |
| 13 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.18733635 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.06277723 |
| 15 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.01380404 |
| 16 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.98519780 |
| 17 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.98416943 |
| 18 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.90850068 |
| 19 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.86400278 |
| 20 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.85214566 |
| 21 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.84065082 |
| 22 | P300_19829295_ChIP-Seq_ESCs_Human | 1.76465660 |
| 23 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.75440754 |
| 24 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.74759015 |
| 25 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.71438721 |
| 26 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.71360568 |
| 27 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.70364477 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.68969472 |
| 29 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.65482012 |
| 30 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.59412996 |
| 31 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.59340079 |
| 32 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59274883 |
| 33 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.55405940 |
| 34 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.53334042 |
| 35 | * STAT3_23295773_ChIP-Seq_U87_Human | 1.53054927 |
| 36 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.51962743 |
| 37 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.51083219 |
| 38 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.51010528 |
| 39 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.50904784 |
| 40 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.50884036 |
| 41 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.50784296 |
| 42 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.46765416 |
| 43 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.44161405 |
| 44 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.43623224 |
| 45 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.41784896 |
| 46 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.40375677 |
| 47 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.39880439 |
| 48 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.38860243 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.38310064 |
| 50 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.37415740 |
| 51 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.37357337 |
| 52 | * TCF4_23295773_ChIP-Seq_U87_Human | 1.37028019 |
| 53 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.37016032 |
| 54 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.37016032 |
| 55 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.36950324 |
| 56 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.36268314 |
| 57 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.34733570 |
| 58 | TP53_16413492_ChIP-PET_HCT116_Human | 1.32395188 |
| 59 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.31455047 |
| 60 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.30961260 |
| 61 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.30679558 |
| 62 | AR_25329375_ChIP-Seq_VCAP_Human | 1.30630678 |
| 63 | * SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.30508135 |
| 64 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.29970916 |
| 65 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.28978479 |
| 66 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28978479 |
| 67 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.27922206 |
| 68 | * CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.26723439 |
| 69 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26673844 |
| 70 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.25557687 |
| 71 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.24642218 |
| 72 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.24313768 |
| 73 | * NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.22158029 |
| 74 | * FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.21817190 |
| 75 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.20240749 |
| 76 | * PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.19316362 |
| 77 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.18538815 |
| 78 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17375428 |
| 79 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.16857714 |
| 80 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.16361408 |
| 81 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.15273497 |
| 82 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.14621313 |
| 83 | FUS_26573619_Chip-Seq_HEK293_Human | 1.14320428 |
| 84 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.14086280 |
| 85 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.13408278 |
| 86 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.13088609 |
| 87 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.12995138 |
| 88 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.12686944 |
| 89 | * EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.12554174 |
| 90 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.11991369 |
| 91 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.11664723 |
| 92 | * MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.11332787 |
| 93 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11116679 |
| 94 | * TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.11105942 |
| 95 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.10261812 |
| 96 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.10261812 |
| 97 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.09953134 |
| 98 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.09892865 |
| 99 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09500313 |
| 100 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08977167 |
| 101 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.08597186 |
| 102 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.08596176 |
| 103 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.07696837 |
| 104 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.06958552 |
| 105 | KDM2B_26808549_Chip-Seq_REH_Human | 1.06929535 |
| 106 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.06682403 |
| 107 | VDR_22108803_ChIP-Seq_LS180_Human | 1.04320014 |
| 108 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.02550409 |
| 109 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.02209348 |
| 110 | * CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.01906173 |
| 111 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.01412511 |
| 112 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.01017606 |
| 113 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00667509 |
| 114 | TBL1_22424771_ChIP-Seq_293T_Human | 0.99710425 |
| 115 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99465059 |
| 116 | CJUN_26792858_Chip-Seq_BT549_Human | 0.98804879 |
| 117 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98063541 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.97863670 |
| 119 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.96244836 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.95333125 |
| 121 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.94898410 |
| 122 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.94451799 |
| 123 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.94451799 |
| 124 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94010934 |
| 125 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.93249866 |
| 126 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.92735363 |
| 127 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.92239266 |
| 128 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.91705047 |
| 129 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.91222730 |
| 130 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.89913189 |
| 131 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89207532 |
| 132 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.88517321 |
| 133 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.88085003 |
| 134 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.87435894 |
| 135 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.85145323 |
| 136 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.82470906 |
| 137 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.79467580 |
| 138 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.78044448 |
| 139 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.77371414 |
| 140 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73505284 |
| 141 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.73350344 |
| 142 | RXR_22108803_ChIP-Seq_LS180_Human | 0.73174578 |
| 143 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.72448583 |
| 144 | GATA2_19941826_ChIP-Seq_K562_Human | 0.71740714 |
| 145 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.69646130 |
| 146 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.69540176 |
| 147 | GATA1_19941826_ChIP-Seq_K562_Human | 0.68805187 |
| 148 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.68120235 |
| 149 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.67610447 |
| 150 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.67244375 |
| 151 | STAT1_17558387_ChIP-Seq_HELA_Human | 0.66334479 |
| 152 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.66150980 |
| 153 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.64984889 |
| 154 | CBP_21632823_ChIP-Seq_H3396_Human | 0.64833699 |
| 155 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.62313178 |
| 156 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.60812502 |
| 157 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.57919076 |
| 158 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.57596047 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 7.04527058 |
| 2 | MP0005360_urolithiasis | 6.69462258 |
| 3 | MP0005365_abnormal_bile_salt | 4.71403454 |
| 4 | MP0003195_calcinosis | 4.69592490 |
| 5 | MP0005085_abnormal_gallbladder_physiolo | 3.94911210 |
| 6 | MP0004043_abnormal_pH_regulation | 3.75616625 |
| 7 | * MP0003252_abnormal_bile_duct | 3.74037973 |
| 8 | MP0005332_abnormal_amino_acid | 3.69762002 |
| 9 | MP0004019_abnormal_vitamin_homeostasis | 3.63540404 |
| 10 | * MP0002138_abnormal_hepatobiliary_system | 3.51279909 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 3.32351656 |
| 12 | MP0005084_abnormal_gallbladder_morpholo | 3.25491868 |
| 13 | MP0009643_abnormal_urine_homeostasis | 2.96218008 |
| 14 | MP0001666_abnormal_nutrient_absorption | 2.71323454 |
| 15 | MP0005083_abnormal_biliary_tract | 2.63141567 |
| 16 | MP0001756_abnormal_urination | 2.44823887 |
| 17 | * MP0002928_abnormal_bile_duct | 2.38572899 |
| 18 | MP0001765_abnormal_ion_homeostasis | 2.31983010 |
| 19 | MP0003879_abnormal_hair_cell | 2.30527465 |
| 20 | MP0005636_abnormal_mineral_homeostasis | 2.11480343 |
| 21 | MP0002136_abnormal_kidney_physiology | 2.08814678 |
| 22 | MP0003806_abnormal_nucleotide_metabolis | 1.84961816 |
| 23 | MP0001958_emphysema | 1.82650069 |
| 24 | MP0010329_abnormal_lipoprotein_level | 1.76363621 |
| 25 | * MP0005220_abnormal_exocrine_pancreas | 1.74292219 |
| 26 | MP0003868_abnormal_feces_composition | 1.63829008 |
| 27 | MP0004264_abnormal_extraembryonic_tissu | 1.56714168 |
| 28 | MP0000534_abnormal_ureter_morphology | 1.55018270 |
| 29 | MP0003136_yellow_coat_color | 1.54564311 |
| 30 | MP0010234_abnormal_vibrissa_follicle | 1.54098002 |
| 31 | MP0002132_abnormal_respiratory_system | 1.44619983 |
| 32 | MP0002118_abnormal_lipid_homeostasis | 1.39575596 |
| 33 | MP0002163_abnormal_gland_morphology | 1.36998006 |
| 34 | MP0002876_abnormal_thyroid_physiology | 1.35493147 |
| 35 | MP0000538_abnormal_urinary_bladder | 1.33325071 |
| 36 | MP0005319_abnormal_enzyme/_coenzyme | 1.31263169 |
| 37 | MP0000609_abnormal_liver_physiology | 1.30376492 |
| 38 | MP0005377_hearing/vestibular/ear_phenot | 1.29238634 |
| 39 | MP0003878_abnormal_ear_physiology | 1.29238634 |
| 40 | MP0008872_abnormal_physiological_respon | 1.28682119 |
| 41 | MP0008961_abnormal_basal_metabolism | 1.23297291 |
| 42 | MP0003191_abnormal_cellular_cholesterol | 1.19486997 |
| 43 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.19150848 |
| 44 | MP0003705_abnormal_hypodermis_morpholog | 1.12889917 |
| 45 | MP0004272_abnormal_basement_membrane | 1.12801415 |
| 46 | MP0003646_muscle_fatigue | 1.12309779 |
| 47 | MP0003283_abnormal_digestive_organ | 1.08263781 |
| 48 | MP0005451_abnormal_body_composition | 1.08135662 |
| 49 | MP0003186_abnormal_redox_activity | 1.06734698 |
| 50 | MP0000383_abnormal_hair_follicle | 1.05330673 |
| 51 | MP0009780_abnormal_chondrocyte_physiolo | 1.05077918 |
| 52 | * MP0002168_other_aberrant_phenotype | 1.05001852 |
| 53 | MP0005058_abnormal_lysosome_morphology | 1.02265322 |
| 54 | MP0001661_extended_life_span | 1.01806944 |
| 55 | MP0001764_abnormal_homeostasis | 0.99481531 |
| 56 | MP0003959_abnormal_lean_body | 0.97773418 |
| 57 | MP0005410_abnormal_fertilization | 0.96527203 |
| 58 | MP0005379_endocrine/exocrine_gland_phen | 0.95773336 |
| 59 | MP0002837_dystrophic_cardiac_calcinosis | 0.95682749 |
| 60 | MP0002896_abnormal_bone_mineralization | 0.91836467 |
| 61 | MP0005670_abnormal_white_adipose | 0.89650210 |
| 62 | MP0000462_abnormal_digestive_system | 0.87573225 |
| 63 | MP0010368_abnormal_lymphatic_system | 0.87485936 |
| 64 | * MP0002135_abnormal_kidney_morphology | 0.87069154 |
| 65 | MP0005171_absent_coat_pigmentation | 0.85117680 |
| 66 | MP0001501_abnormal_sleep_pattern | 0.85110278 |
| 67 | MP0003890_abnormal_embryonic-extraembry | 0.84035126 |
| 68 | * MP0001944_abnormal_pancreas_morphology | 0.83244496 |
| 69 | MP0003950_abnormal_plasma_membrane | 0.82362271 |
| 70 | MP0009384_cardiac_valve_regurgitation | 0.81862002 |
| 71 | MP0003638_abnormal_response/metabolism_ | 0.80287734 |
| 72 | MP0002078_abnormal_glucose_homeostasis | 0.80118761 |
| 73 | MP0005408_hypopigmentation | 0.79018235 |
| 74 | * MP0003943_abnormal_hepatobiliary_system | 0.78938437 |
| 75 | * MP0000598_abnormal_liver_morphology | 0.78866838 |
| 76 | MP0000230_abnormal_systemic_arterial | 0.75078710 |
| 77 | MP0009642_abnormal_blood_homeostasis | 0.73727176 |
| 78 | MP0010386_abnormal_urinary_bladder | 0.72453842 |
| 79 | MP0001485_abnormal_pinna_reflex | 0.70435993 |
| 80 | MP0002796_impaired_skin_barrier | 0.70082933 |
| 81 | MP0002277_abnormal_respiratory_mucosa | 0.69579519 |
| 82 | MP0003183_abnormal_peptide_metabolism | 0.67385392 |
| 83 | * MP0003300_gastrointestinal_ulcer | 0.67349410 |
| 84 | MP0009764_decreased_sensitivity_to | 0.66492040 |
| 85 | MP0005666_abnormal_adipose_tissue | 0.65917051 |
| 86 | MP0005535_abnormal_body_temperature | 0.65819801 |
| 87 | MP0009840_abnormal_foam_cell | 0.64051009 |
| 88 | MP0000566_synostosis | 0.63327925 |
| 89 | MP0005647_abnormal_sex_gland | 0.60762890 |
| 90 | * MP0005395_other_phenotype | 0.60576176 |
| 91 | MP0003941_abnormal_skin_development | 0.59187300 |
| 92 | MP0003953_abnormal_hormone_level | 0.54967922 |
| 93 | MP0004885_abnormal_endolymph | 0.54004430 |
| 94 | MP0008057_abnormal_DNA_replication | 0.53548522 |
| 95 | MP0001984_abnormal_olfaction | 0.52222891 |
| 96 | MP0000013_abnormal_adipose_tissue | 0.50932196 |
| 97 | MP0006276_abnormal_autonomic_nervous | 0.50701539 |
| 98 | MP0008469_abnormal_protein_level | 0.49402116 |
| 99 | MP0005165_increased_susceptibility_to | 0.48952384 |
| 100 | * MP0003045_fibrosis | 0.48748077 |
| 101 | MP0006036_abnormal_mitochondrial_physio | 0.48180855 |
| 102 | MP0000026_abnormal_inner_ear | 0.48040311 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.47580375 |
| 104 | MP0001486_abnormal_startle_reflex | 0.45369607 |
| 105 | MP0003938_abnormal_ear_development | 0.45249030 |
| 106 | MP0001963_abnormal_hearing_physiology | 0.44558724 |
| 107 | MP0002089_abnormal_postnatal_growth/wei | 0.44215923 |
| 108 | MP0003566_abnormal_cell_adhesion | 0.43623237 |
| 109 | MP0000427_abnormal_hair_cycle | 0.43463542 |
| 110 | MP0008004_abnormal_stomach_pH | 0.43372229 |
| 111 | MP0002693_abnormal_pancreas_physiology | 0.43155404 |
| 112 | MP0002295_abnormal_pulmonary_circulatio | 0.42744361 |
| 113 | MP0005501_abnormal_skin_physiology | 0.42301794 |
| 114 | MP0002069_abnormal_eating/drinking_beha | 0.42115109 |
| 115 | MP0009703_decreased_birth_body | 0.41726163 |
| 116 | MP0002098_abnormal_vibrissa_morphology | 0.41661258 |
| 117 | MP0001270_distended_abdomen | 0.40384039 |
| 118 | MP0003172_abnormal_lysosome_physiology | 0.40190478 |
| 119 | MP0000003_abnormal_adipose_tissue | 0.39381048 |
| 120 | MP0001346_abnormal_lacrimal_gland | 0.38957713 |
| 121 | MP0000613_abnormal_salivary_gland | 0.38943519 |
| 122 | MP0006054_spinal_hemorrhage | 0.38813149 |
| 123 | MP0005275_abnormal_skin_tensile | 0.38666090 |
| 124 | MP0004133_heterotaxia | 0.38089990 |
| 125 | MP0005646_abnormal_pituitary_gland | 0.37605665 |
| 126 | MP0009672_abnormal_birth_weight | 0.37389119 |
| 127 | MP0010678_abnormal_skin_adnexa | 0.36950515 |
| 128 | MP0000631_abnormal_neuroendocrine_gland | 0.36362127 |
| 129 | MP0004085_abnormal_heartbeat | 0.35514898 |
| 130 | MP0002254_reproductive_system_inflammat | 0.35194029 |
| 131 | MP0004233_abnormal_muscle_weight | 0.35120215 |
| 132 | MP0001664_abnormal_digestion | 0.34127272 |
| 133 | MP0005334_abnormal_fat_pad | 0.34056262 |
| 134 | MP0009763_increased_sensitivity_to | 0.33699067 |
| 135 | MP0005595_abnormal_vascular_smooth | 0.33138648 |
| 136 | MP0002971_abnormal_brown_adipose | 0.33057272 |
| 137 | MP0002108_abnormal_muscle_morphology | 0.31568431 |
| 138 | MP0002697_abnormal_eye_size | 0.30726626 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Gout (HP:0001997) | 7.68442156 |
| 2 | Increased circulating renin level (HP:0000848) | 6.48283426 |
| 3 | Hypokalemic alkalosis (HP:0001949) | 6.08064987 |
| 4 | Metabolic alkalosis (HP:0200114) | 5.89126559 |
| 5 | Hyperactive renin-angiotensin system (HP:0000841) | 5.62392695 |
| 6 | Hypomagnesemia (HP:0002917) | 5.48091447 |
| 7 | Polyuria (HP:0000103) | 5.20235422 |
| 8 | Abnormality of chloride homeostasis (HP:0011422) | 5.17635424 |
| 9 | Abnormal urine output (HP:0012590) | 5.02586697 |
| 10 | Increased purine levels (HP:0004368) | 4.97897881 |
| 11 | Hyperuricemia (HP:0002149) | 4.97897881 |
| 12 | Abnormality of renal excretion (HP:0011036) | 4.83955404 |
| 13 | Proximal tubulopathy (HP:0000114) | 4.70052349 |
| 14 | Abnormality of purine metabolism (HP:0004352) | 4.61980136 |
| 15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.52395039 |
| 16 | Abnormality of magnesium homeostasis (HP:0004921) | 4.47821110 |
| 17 | Alkalosis (HP:0001948) | 4.34926154 |
| 18 | Hyperglycinuria (HP:0003108) | 4.26223633 |
| 19 | Tetany (HP:0001281) | 4.21748286 |
| 20 | Polydipsia (HP:0001959) | 4.10432591 |
| 21 | Abnormal drinking behavior (HP:0030082) | 4.10432591 |
| 22 | Ketoacidosis (HP:0001993) | 3.98513047 |
| 23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.96672355 |
| 24 | Renal salt wasting (HP:0000127) | 3.91056481 |
| 25 | Abnormality of renin-angiotensin system (HP:0000847) | 3.87968702 |
| 26 | Hyperaldosteronism (HP:0000859) | 3.79524215 |
| 27 | Ketosis (HP:0001946) | 3.71159281 |
| 28 | Abnormality of glycine metabolism (HP:0010895) | 3.62193930 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.62193930 |
| 30 | Abnormality of nucleobase metabolism (HP:0010932) | 3.60564064 |
| 31 | Abnormality of urine glucose concentration (HP:0011016) | 3.49093981 |
| 32 | Glycosuria (HP:0003076) | 3.49093981 |
| 33 | Intrahepatic cholestasis (HP:0001406) | 3.41081495 |
| 34 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.38928906 |
| 35 | Hypokalemia (HP:0002900) | 3.31357121 |
| 36 | Generalized aminoaciduria (HP:0002909) | 3.25026690 |
| 37 | Adrenal overactivity (HP:0002717) | 3.19866235 |
| 38 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.18113154 |
| 39 | Hypoglycemic coma (HP:0001325) | 3.11582845 |
| 40 | Xanthomatosis (HP:0000991) | 3.07453995 |
| 41 | Hyperglycinemia (HP:0002154) | 3.04263720 |
| 42 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.04262036 |
| 43 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.04096990 |
| 44 | Renal tubular acidosis (HP:0001947) | 3.03168786 |
| 45 | Hypercalciuria (HP:0002150) | 3.01791276 |
| 46 | Hyperammonemia (HP:0001987) | 2.97383299 |
| 47 | Late onset (HP:0003584) | 2.95752221 |
| 48 | Vascular calcification (HP:0004934) | 2.82004407 |
| 49 | Cardiovascular calcification (HP:0011915) | 2.79537715 |
| 50 | Deep venous thrombosis (HP:0002625) | 2.75744340 |
| 51 | Abnormality of potassium homeostasis (HP:0011042) | 2.73889111 |
| 52 | Nephrolithiasis (HP:0000787) | 2.64649370 |
| 53 | Abnormality of proline metabolism (HP:0010907) | 2.60111149 |
| 54 | Hydroxyprolinuria (HP:0003080) | 2.60111149 |
| 55 | Delayed CNS myelination (HP:0002188) | 2.53605779 |
| 56 | Bicornuate uterus (HP:0000813) | 2.50655623 |
| 57 | Nephrocalcinosis (HP:0000121) | 2.50190511 |
| 58 | Rickets (HP:0002748) | 2.47796072 |
| 59 | Hyperphosphaturia (HP:0003109) | 2.46703868 |
| 60 | Glomerulosclerosis (HP:0000096) | 2.46589606 |
| 61 | Fat malabsorption (HP:0002630) | 2.42057392 |
| 62 | Abnormal pancreas size (HP:0012094) | 2.38965564 |
| 63 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.35648921 |
| 64 | Hypophosphatemia (HP:0002148) | 2.32962506 |
| 65 | Ileus (HP:0002595) | 2.31855257 |
| 66 | Abnormal urine phosphate concentration (HP:0012599) | 2.28332638 |
| 67 | Exocrine pancreatic insufficiency (HP:0001738) | 2.23563158 |
| 68 | Confusion (HP:0001289) | 2.23079075 |
| 69 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.21388828 |
| 70 | Conjugated hyperbilirubinemia (HP:0002908) | 2.19744161 |
| 71 | Hypoglycemic seizures (HP:0002173) | 2.19479014 |
| 72 | Metabolic acidosis (HP:0001942) | 2.17346689 |
| 73 | Focal segmental glomerulosclerosis (HP:0000097) | 2.16308782 |
| 74 | Malnutrition (HP:0004395) | 2.14592336 |
| 75 | Unilateral renal agenesis (HP:0000122) | 2.13913578 |
| 76 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.13298432 |
| 77 | Dicarboxylic aciduria (HP:0003215) | 2.13298432 |
| 78 | * Dehydration (HP:0001944) | 2.12603943 |
| 79 | Hepatocellular carcinoma (HP:0001402) | 2.11351316 |
| 80 | Amelogenesis imperfecta (HP:0000705) | 2.11295898 |
| 81 | * Facial shape deformation (HP:0011334) | 2.10123963 |
| 82 | * Potter facies (HP:0002009) | 2.10123963 |
| 83 | Hypothermia (HP:0002045) | 2.08587612 |
| 84 | Decreased circulating renin level (HP:0003351) | 2.06634440 |
| 85 | Hypotension (HP:0002615) | 2.05345789 |
| 86 | * Enlarged kidneys (HP:0000105) | 2.02032377 |
| 87 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.01713218 |
| 88 | Widely patent fontanelles and sutures (HP:0004492) | 2.01489521 |
| 89 | Symptomatic seizures (HP:0011145) | 1.99946929 |
| 90 | Thin bony cortex (HP:0002753) | 1.99602388 |
| 91 | Tubular atrophy (HP:0000092) | 1.98267130 |
| 92 | Vomiting (HP:0002013) | 1.98265757 |
| 93 | Chondrocalcinosis (HP:0000934) | 1.97674139 |
| 94 | Joint hemorrhage (HP:0005261) | 1.96389435 |
| 95 | Rectal prolapse (HP:0002035) | 1.95964332 |
| 96 | Abnormality of the common coagulation pathway (HP:0010990) | 1.93761062 |
| 97 | Sensorimotor neuropathy (HP:0007141) | 1.92140532 |
| 98 | Lethargy (HP:0001254) | 1.91708202 |
| 99 | Lymphangioma (HP:0100764) | 1.91032717 |
| 100 | Abnormality of serum amino acid levels (HP:0003112) | 1.90465728 |
| 101 | Prolonged partial thromboplastin time (HP:0003645) | 1.88318461 |
| 102 | Vacuolated lymphocytes (HP:0001922) | 1.87163483 |
| 103 | Irritability (HP:0000737) | 1.87030890 |
| 104 | Generalized muscle weakness (HP:0003324) | 1.85732973 |
| 105 | Abnormality of Sharpey fibers (HP:0100685) | 1.85700763 |
| 106 | Abnormality of macular pigmentation (HP:0008002) | 1.85089418 |
| 107 | Large eyes (HP:0001090) | 1.84346629 |
| 108 | Complement deficiency (HP:0004431) | 1.84249146 |
| 109 | Stage 5 chronic kidney disease (HP:0003774) | 1.83962300 |
| 110 | Steatorrhea (HP:0002570) | 1.83721537 |
| 111 | Abnormality of sodium homeostasis (HP:0010931) | 1.81559370 |
| 112 | Delayed epiphyseal ossification (HP:0002663) | 1.80981092 |
| 113 | Mitral stenosis (HP:0001718) | 1.79302630 |
| 114 | Hyponatremia (HP:0002902) | 1.77392139 |
| 115 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.77168077 |
| 116 | Spastic diplegia (HP:0001264) | 1.76693850 |
| 117 | Hyperkalemia (HP:0002153) | 1.75361484 |
| 118 | Thyroid-stimulating hormone excess (HP:0002925) | 1.72991740 |
| 119 | Male infertility (HP:0003251) | 1.55012369 |
| 120 | Fair hair (HP:0002286) | 1.54086982 |
| 121 | Glomerulonephritis (HP:0000099) | 1.51287262 |
| 122 | Abnormality of complement system (HP:0005339) | 1.47802970 |
| 123 | * Abnormality of the renal medulla (HP:0100957) | 1.45372125 |
| 124 | Hypoplastic labia majora (HP:0000059) | 1.42503770 |
| 125 | Abnormality of the labia majora (HP:0012881) | 1.39384537 |
| 126 | Osteomalacia (HP:0002749) | 1.39317657 |
| 127 | Visceral angiomatosis (HP:0100761) | 1.38854704 |
| 128 | Nephritis (HP:0000123) | 1.38486643 |
| 129 | Hypophosphatemic rickets (HP:0004912) | 1.32752313 |
| 130 | Hemangiomatosis (HP:0007461) | 1.31271630 |
| 131 | Chorioretinal atrophy (HP:0000533) | 1.27920746 |
| 132 | Congenital sensorineural hearing impairment (HP:0008527) | 1.27605973 |
| 133 | Popliteal pterygium (HP:0009756) | 1.27465466 |
| 134 | Nephrogenic diabetes insipidus (HP:0009806) | 1.23568986 |
| 135 | Impaired platelet aggregation (HP:0003540) | 1.23194901 |
| 136 | Abnormal platelet function (HP:0011869) | 1.23194901 |
| 137 | Hypoplasia of the uterus (HP:0000013) | 1.22780962 |
| 138 | Abnormal biliary tract morphology (HP:0012440) | 1.19082604 |
| 139 | Renal hypoplasia (HP:0000089) | 1.18585797 |
| 140 | Abnormality of the dental pulp (HP:0006479) | 1.15923529 |
| 141 | Taurodontia (HP:0000679) | 1.15358970 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK3 | 7.66787475 |
| 2 | WNK4 | 6.57286751 |
| 3 | OXSR1 | 5.67645656 |
| 4 | STK39 | 3.14871765 |
| 5 | BCKDK | 3.02612214 |
| 6 | INSRR | 2.67683280 |
| 7 | FRK | 2.40015856 |
| 8 | STK38L | 2.29533329 |
| 9 | FGFR4 | 2.20847039 |
| 10 | LATS1 | 2.00735304 |
| 11 | MAPK15 | 1.97901684 |
| 12 | MST1R | 1.92482418 |
| 13 | ERN1 | 1.61342571 |
| 14 | SGK223 | 1.49777570 |
| 15 | SGK494 | 1.49777570 |
| 16 | SIK1 | 1.47538582 |
| 17 | TAOK3 | 1.45751139 |
| 18 | PTK6 | 1.39731469 |
| 19 | ERBB4 | 1.36224502 |
| 20 | BMPR1B | 1.35616339 |
| 21 | PTK2 | 1.26600267 |
| 22 | SGK3 | 1.24103655 |
| 23 | PIK3CG | 1.22991652 |
| 24 | WNK1 | 1.22148938 |
| 25 | LATS2 | 1.21499085 |
| 26 | DYRK1B | 1.21419927 |
| 27 | SGK2 | 1.14124291 |
| 28 | NLK | 1.12393834 |
| 29 | MST4 | 1.11689460 |
| 30 | ACVR1B | 1.11246668 |
| 31 | EPHB1 | 1.11207820 |
| 32 | RIPK1 | 1.10827921 |
| 33 | FGFR2 | 1.05776025 |
| 34 | EPHA2 | 1.03082985 |
| 35 | STK38 | 0.96488424 |
| 36 | PDK4 | 0.92910461 |
| 37 | PDK3 | 0.92910461 |
| 38 | MET | 0.90465705 |
| 39 | MAP3K2 | 0.90361917 |
| 40 | FER | 0.89825371 |
| 41 | GSK3A | 0.89269518 |
| 42 | LRRK2 | 0.88765342 |
| 43 | MAP3K7 | 0.86755831 |
| 44 | TRIB3 | 0.76508073 |
| 45 | PRKAA2 | 0.75826743 |
| 46 | TGFBR2 | 0.75811068 |
| 47 | NEK9 | 0.72980690 |
| 48 | TNIK | 0.72439558 |
| 49 | PAK4 | 0.70703632 |
| 50 | CAMK1D | 0.67042248 |
| 51 | NTRK3 | 0.66872619 |
| 52 | TIE1 | 0.66839860 |
| 53 | PRKAA1 | 0.63734843 |
| 54 | PDGFRA | 0.62865587 |
| 55 | MELK | 0.62728825 |
| 56 | PDK2 | 0.59721224 |
| 57 | MAPK11 | 0.59454829 |
| 58 | AKT3 | 0.59156858 |
| 59 | PIK3CA | 0.58995086 |
| 60 | LMTK2 | 0.58921319 |
| 61 | PAK3 | 0.58411768 |
| 62 | PRKD2 | 0.58036767 |
| 63 | MAP3K3 | 0.56343684 |
| 64 | PRKD3 | 0.54279886 |
| 65 | ERBB2 | 0.54184403 |
| 66 | GRK1 | 0.53769506 |
| 67 | ADRBK2 | 0.53265825 |
| 68 | CAMK1G | 0.51961673 |
| 69 | STK10 | 0.51957213 |
| 70 | MAP4K2 | 0.51296614 |
| 71 | MTOR | 0.51209691 |
| 72 | PRKCZ | 0.50790774 |
| 73 | FGFR3 | 0.49028202 |
| 74 | SGK1 | 0.45597919 |
| 75 | PRKCI | 0.44992657 |
| 76 | JAK2 | 0.44461975 |
| 77 | STK3 | 0.43932595 |
| 78 | STK24 | 0.42162362 |
| 79 | TGFBR1 | 0.41542942 |
| 80 | ABL2 | 0.39819979 |
| 81 | PINK1 | 0.39238881 |
| 82 | NTRK1 | 0.38759234 |
| 83 | DDR2 | 0.38681850 |
| 84 | TTN | 0.38572784 |
| 85 | BCR | 0.37951792 |
| 86 | MAP3K14 | 0.37782705 |
| 87 | PKN2 | 0.35546621 |
| 88 | BRD4 | 0.34164113 |
| 89 | PRKCH | 0.34062267 |
| 90 | PDPK1 | 0.33504672 |
| 91 | EIF2AK3 | 0.32499796 |
| 92 | MAP2K2 | 0.31766935 |
| 93 | EPHB2 | 0.31514376 |
| 94 | TRPM7 | 0.30710338 |
| 95 | CSK | 0.29064210 |
| 96 | CSNK1A1 | 0.28977562 |
| 97 | MAP2K1 | 0.28771449 |
| 98 | DAPK2 | 0.26760840 |
| 99 | BMX | 0.26746656 |
| 100 | CSNK1A1L | 0.26387225 |
| 101 | IRAK3 | 0.26316265 |
| 102 | PRKACG | 0.26314567 |
| 103 | NEK1 | 0.26163554 |
| 104 | IGF1R | 0.26056464 |
| 105 | FGFR1 | 0.26048635 |
| 106 | PRKACA | 0.23767607 |
| 107 | JAK1 | 0.23628388 |
| 108 | CHUK | 0.22939424 |
| 109 | PASK | 0.22536267 |
| 110 | BRSK2 | 0.22451537 |
| 111 | PRKG1 | 0.21842763 |
| 112 | CASK | 0.21365626 |
| 113 | KDR | 0.21303617 |
| 114 | CSNK1G1 | 0.21104784 |
| 115 | ROCK1 | 0.20385936 |
| 116 | NUAK1 | 0.19660275 |
| 117 | SCYL2 | 0.19361926 |
| 118 | MARK2 | 0.19230947 |
| 119 | ADRBK1 | 0.19183358 |
| 120 | PDGFRB | 0.18348120 |
| 121 | INSR | 0.18144838 |
| 122 | NME1 | 0.17686661 |
| 123 | MYLK | 0.17569957 |
| 124 | PRKCA | 0.17422194 |
| 125 | ABL1 | 0.17081822 |
| 126 | PRKG2 | 0.15659574 |
| 127 | EGFR | 0.15548524 |
| 128 | ZAK | 0.14927835 |
| 129 | PRKCQ | 0.14922907 |
| 130 | MAPKAPK3 | 0.14815558 |
| 131 | PRKCE | 0.14796030 |
| 132 | MKNK2 | 0.14434106 |
| 133 | PRKCG | 0.14281180 |
| 134 | MAP3K4 | 0.13899215 |
| 135 | PRKACB | 0.13177812 |
| 136 | PRKD1 | 0.13108236 |
| 137 | CSNK1D | 0.12449042 |
| 138 | TNK2 | 0.12095394 |
| 139 | STK11 | 0.11102003 |
| 140 | PDK1 | 0.10998028 |
| 141 | RPS6KA3 | 0.10913609 |
| 142 | KIT | 0.10878409 |
| 143 | PRKCB | 0.08753258 |
| 144 | IKBKB | 0.08109471 |
| 145 | EPHA3 | 0.07898162 |
| 146 | MAPK1 | 0.07334243 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12693449 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.90234387 |
| 3 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.83205547 |
| 4 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.82873841 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.75843177 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.74352226 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.68439226 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.61447323 |
| 9 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.55213566 |
| 10 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54393627 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.50052342 |
| 12 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.48488610 |
| 13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.38032026 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.24091147 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.21516889 |
| 16 | Peroxisome_Homo sapiens_hsa04146 | 2.20570251 |
| 17 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 2.19702973 |
| 18 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.11958037 |
| 19 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.07170616 |
| 20 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.06371398 |
| 21 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.02598845 |
| 22 | Bile secretion_Homo sapiens_hsa04976 | 1.84753105 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.81056601 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.79458790 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72588583 |
| 26 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.70227231 |
| 27 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.69496377 |
| 28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.64882071 |
| 29 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58737188 |
| 30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.56305023 |
| 31 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.56209677 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.45850179 |
| 33 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.42954351 |
| 34 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.37977541 |
| 35 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.37643933 |
| 36 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.35460614 |
| 37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.35311118 |
| 38 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35157113 |
| 39 | Lysine degradation_Homo sapiens_hsa00310 | 1.31295948 |
| 40 | Carbon metabolism_Homo sapiens_hsa01200 | 1.23081572 |
| 41 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.22712688 |
| 42 | ABC transporters_Homo sapiens_hsa02010 | 1.19091338 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.18613432 |
| 44 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17255695 |
| 45 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.15466797 |
| 46 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.13484443 |
| 47 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.13313704 |
| 48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.08485237 |
| 49 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.07874334 |
| 50 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.06292563 |
| 51 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.04891732 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.03007156 |
| 53 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02128512 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.00228075 |
| 55 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.97318389 |
| 56 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.92349089 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 0.88427094 |
| 58 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.86401525 |
| 59 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.85298337 |
| 60 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.83445266 |
| 61 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.78308166 |
| 62 | Mineral absorption_Homo sapiens_hsa04978 | 0.74184398 |
| 63 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73859739 |
| 64 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.72629848 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.70218556 |
| 66 | Phototransduction_Homo sapiens_hsa04744 | 0.70069455 |
| 67 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67385571 |
| 68 | Other glycan degradation_Homo sapiens_hsa00511 | 0.65984953 |
| 69 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.64450647 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60099037 |
| 71 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.58335502 |
| 72 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.55620006 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.53088113 |
| 74 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.53069008 |
| 75 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.50381155 |
| 76 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.45760449 |
| 77 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.44997288 |
| 78 | Hepatitis C_Homo sapiens_hsa05160 | 0.43837094 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.42893275 |
| 80 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.41463694 |
| 81 | Metabolic pathways_Homo sapiens_hsa01100 | 0.40565964 |
| 82 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.40550931 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.39349613 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38643154 |
| 85 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38532709 |
| 86 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.37016217 |
| 87 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.36544798 |
| 88 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.35911960 |
| 89 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.34775391 |
| 90 | Insulin resistance_Homo sapiens_hsa04931 | 0.33891880 |
| 91 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33119147 |
| 92 | Lysosome_Homo sapiens_hsa04142 | 0.32826254 |
| 93 | Salivary secretion_Homo sapiens_hsa04970 | 0.27896262 |
| 94 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.27290487 |
| 95 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.26740256 |
| 96 | Nicotine addiction_Homo sapiens_hsa05033 | 0.26091738 |
| 97 | Bladder cancer_Homo sapiens_hsa05219 | 0.25543580 |
| 98 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24055459 |
| 99 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23862806 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.23209011 |
| 101 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.21217375 |
| 102 | Melanoma_Homo sapiens_hsa05218 | 0.20778597 |
| 103 | Renin secretion_Homo sapiens_hsa04924 | 0.20723552 |
| 104 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.20527829 |
| 105 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.20271984 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.19606325 |
| 107 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.17111791 |
| 108 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.16673218 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16614907 |
| 110 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.16297559 |
| 111 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16183787 |
| 112 | GABAergic synapse_Homo sapiens_hsa04727 | 0.15168781 |
| 113 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.14911415 |
| 114 | Prostate cancer_Homo sapiens_hsa05215 | 0.14459181 |
| 115 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.13772779 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.10263662 |
| 117 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.10229724 |
| 118 | Adherens junction_Homo sapiens_hsa04520 | 0.09781452 |
| 119 | Focal adhesion_Homo sapiens_hsa04510 | 0.09643471 |
| 120 | Tight junction_Homo sapiens_hsa04530 | 0.09231430 |
| 121 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.04417170 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.04299139 |
| 123 | Galactose metabolism_Homo sapiens_hsa00052 | 0.02404432 |
| 124 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.02161717 |
| 125 | Amoebiasis_Homo sapiens_hsa05146 | 0.01594704 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.01053508 |
| 127 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.00747238 |
| 128 | Linoleic acid metabolism_Homo sapiens_hsa00591 | -0.0041256 |
| 129 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | -0.0029604 |

